These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7810837)

  • 1. [Markers in the evolution and control of HIV infection].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 1994; 111(2):273-87. PubMed ID: 7810837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Virological diagnosis of HIV infection in children].
    Muñoz Fernández MA
    Allergol Immunopathol (Madr); 1998; 26(3):122-9. PubMed ID: 9675394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. People with HIV misunderstand viral-load tests.
    AIDS Alert; 1999 Feb; 14(2):suppl 1-2. PubMed ID: 11366177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to AIDS virus infection: good, bad, or both?
    Deeks SG; Walker BD
    J Clin Invest; 2004 Mar; 113(6):808-10. PubMed ID: 15067312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic assays for HIV-1 infection.
    Truong HM; Klausner JD
    MLO Med Lab Obs; 2004 Jul; 36(7):12-3, 16, 18-20; quiz 22-3. PubMed ID: 15318787
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years of HIV-1 research: what the future holds.
    Imami N; Gotch F
    Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contemporary opinions on the clinical symptoms, diagnosis and treatment of primary HIV infection].
    Knysz B; Gasiorowski J; Czarnecki M; Gładysz A
    Wiad Lek; 2004; 57(5-6):267-70. PubMed ID: 15518074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CD127 expression links immune activation and CD4(+) T cell loss in HIV infection.
    Kiazyk SA; Fowke KR
    Trends Microbiol; 2008 Dec; 16(12):567-73. PubMed ID: 18964017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the intra-host dynamics of HIV-1 infections.
    Stilianakis NI; Schenzle D
    Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid HIV test a breakthrough in early detection, treatment.
    Dis Manag Advis; 2003 Mar; 9(3):33-6. PubMed ID: 12701447
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 15. Surrogate markers of immune function in human immunodeficiency virus-infected patients: what are they surrogates for?
    Hengel RL; Kovacs JA
    J Infect Dis; 2003 Dec; 188(12):1791-3. PubMed ID: 14673756
    [No Abstract]   [Full Text] [Related]  

  • 16. Unraveling the strands of HIV's web.
    Pantaleo G
    Nat Med; 1999 Jan; 5(1):27-8. PubMed ID: 9883835
    [No Abstract]   [Full Text] [Related]  

  • 17. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
    Malhotra U; Bosch RJ; Chan E; Wang R; Fischl MA; Collier AC; McElrath MJ
    J Infect Dis; 2004 Feb; 189(3):515-9. PubMed ID: 14745710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T-lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV-1) and healthy population in Jos, Nigeria.
    Njoku MO; Sirisena ND; Idoko JA; Jelpe D
    Niger Postgrad Med J; 2003 Sep; 10(3):135-9. PubMed ID: 14692053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.